首页|Combined targeting of CCL7 and Flt3L to promote the expansion and infiltration of cDC1s in tumors enhances T-cell activation and anti-PD-1 therapy effectiveness in NSCLC

Combined targeting of CCL7 and Flt3L to promote the expansion and infiltration of cDC1s in tumors enhances T-cell activation and anti-PD-1 therapy effectiveness in NSCLC

扫码查看
原文链接
  • 万方数据

Hong-Peng Dong、Ying Li、Zhen Tang、Peng Wang、Bo Zhong、Qian Chu、Dandan Lin

展开 >

Cancer Center,Renmin Hospital of Wuhan University,Medical Research Institute and Frontier Science Center of Immunology and Metabolism,Wuhan University,Wuhan 430071,China

College of Life Sciences,Wuhan University,Wuhan 430072,China

CAS Key Laboratory of Infection and Immunity,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China

TaiKang Center for Life and Medical Sciences,Wuhan University,Wuhan 430071,China

Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China

展开 >

National Key Research and Development Program of ChinaNatural Science Foundation of ChinaNatural Science Foundation of ChinaNatural Science Foundation of ChinaFundamental Research Funds for the Central Universities

2022YFC34015003193004032070900322709512042022kf1187

2023

10.1038/s41423-023-00991-5

中国免疫学杂志(英文版)
中国免疫学会

中国免疫学杂志(英文版)

CSTPCDCSCDSCI
影响因子：0.731
ISSN：1672-7681
年,卷(期)：2023.20(7)
  • 10